Cargando…

Hydroxychloroquine Reduces Proteinuria in Indian Patients With IgA Nephropathy

Detalles Bibliográficos
Autores principales:	Bagchi, Soumita, Bhowmik, Dipankar, Singh, Geetika, Agarwal, Sanjay Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171695/ https://www.ncbi.nlm.nih.gov/pubmed/35685311 http://dx.doi.org/10.1016/j.ekir.2022.04.086

Ejemplares similares

Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
por: Bagchi, Soumita, et al.
Publicado: (2021)

Association of vitamin D status with disease severity and outcome in Indian patients with IgA nephropathy
por: Farooqui, Naba, et al.
Publicado: (2023)

The International IgA Nephropathy Network Prediction Tool Underestimates Disease Progression in Indian Patients
por: Bagchi, Soumita, et al.
Publicado: (2022)

Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study
por: Bagchi, Soumita, et al.
Publicado: (2019)

Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Goswami, R. P., et al.
Publicado: (2013)

Comment on: Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Nasri, H.
Publicado: (2014)

Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analysis
por: Zhang, Jialing, et al.
Publicado: (2021)

KM55 in the Evaluation of IgA-Containing Glomerular Diseases
por: Raj, Rahul, et al.
Publicado: (2021)

Profile of Indian Patients With Membranous Nephropathy
por: Subramanian, Priyadarsani, et al.
Publicado: (2020)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience
por: Bagchi, Soumita, et al.
Publicado: (2018)

Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study
por: Yang, Ya-zi, et al.
Publicado: (2019)

Moxifloxacin-associated Neutropenia in a Patient Planned for Renal Transplantation
por: Subbiah, Arunkumar, et al.
Publicado: (2019)

IgA Nephropathy in a Patient with IgG Myeloma
por: Lakshmi, B. Sangeeta, et al.
Publicado: (2018)

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission
por: Inagaki, Koji, et al.
Publicado: (2017)

R: IgG deposition in IgA nephropathy patients
por: Baradaran, Azar
Publicado: (2013)

IgA nephropathy in IgG kappa multiple myeloma
por: Couto, Maria Eduarda, et al.
Publicado: (2021)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy
por: Hu, Tingyang, et al.
Publicado: (2018)

Hydroxychloroquine in IgA nephropathy: a systematic review
por: Stefan, Gabriel, et al.
Publicado: (2021)

Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022)

Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
por: Hastings, M. Colleen, et al.
Publicado: (2012)

Beta-Thalassemia Minor Is Associated with IgA Nephropathy
por: Kang, Jung Hyun, et al.
Publicado: (2013)

Canagliflozin Markedly Decreased Proteinuria in a Patient With IgA Nephropathy
por: Aameish, Muhammad, et al.
Publicado: (2021)

Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021)

Antiglomerular Basement Membrane Disease Combined with IgA Nephropathy
por: Gupta, Yashita, et al.
Publicado: (2019)

Sulodexide in IgA nephropathy
Publicado: (2013)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy
por: Sarcina, Cristina, et al.
Publicado: (2016)

Severity of foot process effacement is associated with proteinuria in patients with IgA nephropathy
por: Lee, Ji-Hye, et al.
Publicado: (2020)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
por: Dong, Yaping, et al.
Publicado: (2023)

IgA nephropathy following COVID-19 vaccination: challenges and perspectives
por: Niel, Olivier, et al.
Publicado: (2022)

Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria
por: Komatsu, Hiroyuki, et al.
Publicado: (2015)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

IgA Staining Patterns Differentiate Between IgA Nephropathy and IgA-Dominant Infection-Associated Glomerulonephritis
por: Brodsky, Sergey V., et al.
Publicado: (2020)

De-Novo Focal Crescentic IgA Nephropathy in a Renal Allograft Recipient
por: Ramasamy, Ashok, et al.
Publicado: (2019)

Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination
por: Leong, Leanne Ca-Yin, et al.
Publicado: (2021)

Renal abnormalities in rheumatoid arthritis: an insight on IgA nephropathy
por: Prata, Ana R, et al.
Publicado: (2021)

Author response on: Malignant hypertension and nephrotic range proteinuria without hematuria: IgA nephropathy
por: Goswami, R. P., et al.
Publicado: (2014)

Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria
por: Ruan, Yiping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h2pln1h4ta4qi1jlcsfk8g42gh